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Ca21 ion concentration changes are critical events in
signal transduction. The Ca21-dependent interactions of
calmodulin (CaM) with its target proteins play an essen-
tial role in a variety of cellular functions. In this study,
we investigated the interactions of G protein bg sub-
units with CaM. We found that CaM binds to known bg
subunits and these interactions are Ca21-dependent.
The CaM-binding domain in Gbg subunits is identified
as Gb residues 40–63. Peptides derived from the Gb
protein not only produce a Ca21-dependent gel mobility
shifting of CaM but also inhibit the CaM-mediated acti-
vation of CaM kinase II. Specific amino acid residues
critical for the binding of Gbg to CaM were also identi-
fied. We then investigated the potential function of
these interactions and showed that binding of CaM to
Gbg inhibits the pertussis toxin-catalyzed ADP-ribosyl-
ation of Gao subunits, presumably by inhibiting hetero-
trimer formation. Furthermore, we demonstrated that
interaction with CaM has little effect on the activation
of phospholipase C-b2 by Gbg subunits, supporting the
notion that different domains of Gbg are responsible for
the interactions of different effectors. These findings
shed light on the molecular basis for the interactions of
Gbg with Ca21-CaM and point to the potential physio-
logical significance of these interactions in cellular
functions.
In response to external stimuli or changes in ligand concen-
tration, the activated seven-transmembrane receptors of the
cell interact with heterotrimeric G proteins. These in turn
activate or inhibit a variety of intracellular proteins through
either the Ga subunits with GTP bound or the free Gbg sub-
units or both, leading to the generation of second-messenger
molecules and changes in the patterns of cellular metabolic
activity and growth. Whereas direct interaction of G protein a
subunits with effectors has been known for a long time, re-
cently it has been demonstrated that Gbg subunits also play
critical roles in effector activation, in modulating the interac-
tion among various G protein pathways, and in regulating
cellular functions. For example, the Gbg dimers have been
shown to participate in interactions with adenylyl cyclases (1),
phospholipases (2, 3), phosducin (4), b-adrenergic receptor ki-
nases (5–7), Bruton tyrosine kinase (8), inositol trisphosphate
kinases (9, 10), mitogen-activated protein kinase (11), and a
number of ion channels (12–16). The activation of phospho-
lipase C-b2 and b3 by Gbg has been suggested to account for
the PTX1-sensitive increase in intracellular Ca21 in response to
a number of chemoattractants (17, 18) and other ligands, thus
regulating intracellular Ca21 concentration.
Calmodulin (CaM) has been known to act as an intracellular
calcium sensor protein. When the intracellular Ca21 concen-
tration increases, CaM can bind up to four Ca21 ions, changing
its conformation and regulating cellular functions such as ac-
tivation or inhibition of a large number of enzymes (19, 20), ion
channels (21), and receptors (22). These Ca21-dependent inter-
actions of CaM with its target proteins have played an impor-
tant role in intracellular Ca21 signaling and in various cellular
functions including cell growth and differentiation. There are
reports demonstrating that G protein bg complex can bind to
CaM when passed through the CaM-agarose column (23, 24);
however, the precise nature of the interaction is not clear.
In this report, we investigated the interaction of Ca21-CaM
with Gbg subunits and the potential physiological significance
of this interaction. We found that CaM not only binds to Gbg
subunits purified from brain but also to the most diverse Gb5Lg
complex from retina. We then identified and characterized the
CaM-binding domain of the Gb subunit by using synthetic
peptides and site-specific mutation. Furthermore, we showed
that binding of CaM to bg inhibits the bg-dependent PTX-
catalyzed ADP-ribosylation of Ga subunits. Using both brain
Gbg subunits and the CaM-binding peptide derived from the b
subunit, we demonstrated that the Ca21-CaM-dependent acti-
vation of CaM kinase II could be inhibited at a molar ratio of 1
(peptide/CaM). These studies provide insight into the molecu-
lar basis for the interactions of bg with Ca21-CaM and the
potential functions of these interactions in modulating cellular
signaling and other functions.
EXPERIMENTAL PROCEDURES
Materials
Synthetic peptides were obtained from the Peptide Synthesis Facility
(Beckman Institute, California Institute of Technology). Peptides were
purified by high performance liquid chromatography and verified by
mass spectrometry. Bovine brain CaM was purchased from Calbiochem.
Phosphatidylethanolamine and phosphatidylinositol-4,5-diphosphate
(PtdInsP2) were purchased from Avanti Polar Lipids (Alabaster, AL)
and Boehringer Manheim, respectively. [3H]PtdInsP2, myo-[2-
3H]inosi-
tol, and [32P]NAD were obtained from DuPont NEN. Pertussis toxin
was purchased from List Biological Laboratories Inc.
CaM Binding Assay of G Protein b5Lg Subunits
Bleached bovine rod outer segment membranes were prepared from
bovine retina as described (25). Transducin was removed from the
membranes by 6 3 hypotonic elution with 100 mM GTPgS in the pres-
ence of 3 mM MgCl2 (26). The remaining membranes were solubilized
for 12 h at 4 °C in 20 ml of a buffer containing 50 mM Hepes, pH 8.0, 100
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mM NaCl, 3 mM MgCl2, 10 mM 2-mercaptoethanol, and 1% (by mass)
sodium cholate. Unsolubilized material was pelleted for 40 min at
100,000 3 g, and the supernatant was diluted with 30 ml of a buffer
containing 50 mM Hepes, pH 8.0, 100 mM NaCl, 3 mM MgCl2, 10 mM
2-mercaptoethanol, and 1.67 mM CaCl2 (final concentration: 1 mM
CaCl2, 0.4% sodium cholate). The diluted supernatant was then applied
at a flow rate of 0.3 ml/min to a CaM-Sepharose column (10-ml bed
volume, Pharmacia Biotech Inc.) equilibrated with the above described
buffer. The column was washed with 50 ml of the above buffer. Proteins
bound to the CaM-Sepharose column were then isocratically eluted
with a buffer containing 50 mM Hepes, pH 8.0, 100 mM NaCl, 3 mM
MgCl2, 10 mM 2-mercaptoethanol, 10 mM EDTA, and 0.4% sodium
cholate. Fractions of 600 ml were collected. 20 ml of the indicated
fractions were separated by 10% SDS-PAGE and immunoblotted using
the Gb5-specific antiserum CT215 as described (27).
Gel Mobility Shifting and Gel Overlay Assays
High affinity binding of G protein b peptides to CaM was demon-
strated by the gel mobility shifts of CaM in 12.5% nondenaturing
polyacrylamide gels in the presence or absence of 4 M urea. Different
concentrations of Gb peptide were incubated with 1 mM CaM at room
temperature for 30 min. To determine the Ca21 dependence and bind-
ing stoichiometry, gels were run in the presence of either 0.5 mM CaCl2
or 2 mM EGTA. Proteins were visualized by Coomassie Brilliant Blue
staining.
Fluorescence Measurements and Determination of
Dissociation Constants
Fluorescence emission spectra were obtained using SLM 4800 spec-
trofluorimeter. Excitation was at 295 nm. Excitation and emission
band-passes were both 10 nm. Total fluorescence was determined by
integration of emission spectra. The fluorescence titration data was
used to determine the dissociation constant as described previously
(28). By plotting the fraction of bound peptide as a function of free CaM
concentrations, we obtained the peptide-CaM titration curve. The dis-
sociation constant for the peptide-CaM binding was obtained from the
curve fitting.
Site-specific Mutagenesis
Mutations in the putative CaM-binding site of Gb1 were generated by
polymerase chain reaction with the high fidelity DNA polymerase, Pfu
(Stratagene). The mutations were confirmed by DNA sequencing done
in the DNA sequencing facility at Caltech. The b constructs were
subcloned into pCDNA3.1 vector (Invitrogen, San Diego, CA).
In Vitro Translation and Binding Assays
Transcription and translation were carried out using a rabbit reticu-
locyte lysate system from Promega at 30 °C for 90 min with amino acid
mixtures without methionine. 5 mCi of [35S]methionine (.1000 Ci/
mmol, DuPont NEN) was added to the reaction mixture to monitor the
synthesis of new proteins. 1–2 mg of cDNAs were used in each transla-
tion. 2.5 ml aliquots of the translation mixture were separated on 12%
SDS-PAGE. The newly synthesized proteins were identified by autora-
diography. After in vitro translation, the protein mixture was incubated
with CaM-agarose beads in the presence of Ca21 for 30 min at room
temperature. Then the CaM-agarose beads were washed extensively to
get rid of nonspecific binding. Proteins bound to the beads were eluted
by a buffer containing 10 mM EGTA. The eluted Gb proteins were
separated by SDS-PAGE and visualized by autoradiography.
ADP-ribosylation of Gao Subunits by PTX
Pertussis toxin-catalyzed ADP-ribosylation of Gao was performed as
described previously (29). Briefly, 0.1 mg of recombinant Gao was mixed
with 0.1 mg of purified rat brain bg subunits in the absence or presence
of Ca21-CaM and incubated for 10 min at room temperature before the
addition of the reaction mixture (20 mM Tris-HCl, pH 8.0, 1 mM EDTA,
2 mM MgCl2, 2 mM dithiothreitol, 0.5 mM
32P-labeled NAD (20,000
cpm/pmol), and 10 mg/ml pertussis toxin). Reactions were incubated at
room temperature for 30 min and terminated by adding 5 3 SDS-PAGE
sample buffer. Samples were resolved on SDS-polyacrylamide gels and
stained with Coomassie Blue. Labeling of proteins was detected by
autoradiography.
Enzymatic Activity Assays of CaM Kinase II
The Ca21-CaM-dependent activity of CaM kinase II was assayed
essentially as described previously (30). Briefly, different concentra-
tions of Gb peptide were preincubated with Ca21-CaM for 30 min at
room temperature. The phosphorylation reactions contained 50 mM
Hepes buffer, pH 7.5, 10 mM magnesium acetate, 1 mM CaCl2, 0.1 mM
[g-32P]ATP, 1 mM CaM, 5–10 mg of CaM kinase II peptide substrate
(Chemicon International, Inc., Temecula, CA), and purified rat brain
CaM kinase II (Calbiochem). All assays were initiated by the addition of
kinase.
COS-7 Cell Transfection and Phosphoinositol Phospholipase C
Activity Assays
In Vivo Transfection Assay—cDNAs encoding PLC-b2, Gbg, and
CaM were cotransfected into COS-7 cells with LipofectAMINE (Life
Technologies, Inc.). Then the cells were labeled with 10 mCi/ml myo-[2-
3H]inositol the following day. 48 h after transfection, the activity of
PLC-b2 was assayed by determining the levels of inositol phosphates as
described previously (31, 37).
In Vitro Reconstitution Assay of PLC-b2 Activity— Phospholipid ves-
icles containing 50 mM [3H]PtdInsP2 and 500 mM phophatidylethanol-
amine were prepared by mixing with chloroform solution, drying under
a stream of N2, then sonicating with 88 mM Hepes buffer, pH 7.5, and
18 mM LiCl. Assays were performed in a 70-ml reaction mixture con-
taining 20 ng of PLC-b2, 1.7 mM Gbg from bovine retina, 50 mM CaCl2,
10 mM LiCl, and phospholipid vesicles. The reaction mixtures were
incubated at 30 °C for 10 min in the presence of different concentrations
of CaM. The reactions were stopped by adding 0.35 ml of chloroform/
methanol/HCl (500:500:3). The released Ins-1,4,5-P3 was extracted by
adding 0.1 ml of 1 M HCl with vigorous vortexing. The aqueous phase
separated after centrifugation was subjected to scintillation counting.
RESULTS
Binding of Gbg Subunits to Ca21-CaM—To demonstrate the
direct interaction of Gbg subunits with CaM, purified bovine
brain bg subunits were incubated with CaM-agarose gel in the
presence of 1 mM CaCl2. After extensively washing with Ca
21-
containing buffer, the bound bg subunits were eluted by buffer
containing EGTA. As shown in Fig. 1A, brain bg binds to CaM,
and this binding is Ca21-dependent. Direct binding was also
observed in a gel overlay assay with 125I-labeled CaM (data not
shown). There are five different G protein b subunits that have
been characterized in mammalian systems. Among them, Gb5
is the most diverse form and is expressed predominately in
neuronal cells (27). A splice variant of Gb5, b5L, is found only in
rod outer segment membrane. To examine whether CaM bind-
ing is a common feature in different bg subunits, Gb5Lg ex-
tracts were obtained from bovine retina and passed through a
CaM-agarose fast protein liquid chromatography column in the
presence of Ca21. Proteins bound to the CaM-agarose column
were eluted with buffer containing 10 mM EDTA and detected
by specific antibodies against the Gb5 subunit. Like other bg
subunits, b5Lg also binds to Ca
21-CaM (Fig. 1B), suggesting
that the CaM-binding domain is conserved in all Gbg subunits.
Identification of a CaM-binding Domain of Gbg Sub-
units—To identify the CaM-binding domain on Gbg subunits,
the amino acid sequences of bg were compared with those of
known high affinity CaM-binding proteins. We found that the
N terminus of all Gb subunits contains a putative CaM-binding
domain that exhibits the characteristics typical of CaM-binding
peptides (32). Fig. 2 shows the alignment of the N-terminal
domain sequences of Gb subunits with well known CaM-bind-
ing domains of rat olfactory cyclic nucleotide-gated channel
(RAT OCNC), skeletal muscle myosin light chain kinase (SK-
MLCK), Ca21 pump, calcineurin, Ras-like GTPase Kir/Gem,
murine inducible nitric oxide synthase (iNOS), and CaM ki-
nase II. To demonstrate that the small domain from amino acid
residues Val-40–Trp-63 is indeed the CaM-binding domain of
Gb subunits, synthetic peptides representing the putative
CaM-binding domain were prepared and tested for their abili-
ties to bind CaM in the presence of Ca21 using both gel mobility
shifting assay and tryptophan fluorescence assays.
Binding of peptides to CaM was first assayed by nondena-
turing polyacrylamide gel shifting assay. Depending on the
Ca21-CaM-binding Domain in G Protein bg Subunits18802
charges and hydrophobicity of the peptide, high affinity bind-
ing of the peptide to CaM was detected as a complex band with
increased or decreased mobility compared with the unbound
CaM band. In the presence of Ca21, the mobility of CaM was
decreased by the peptide corresponding to Gb residues 40–63
(Fig. 3A). Several ratios of the peptide to CaM were used. In the
absence of peptide, there is a single, fast-moving band reflect-
ing pure Ca21-CaM (Fig. 3A, CaM alone). At ratios of 0.25 and
0.75 of peptide to CaM, two bands were visible on the gel, the
fast-moving CaM band and the lower mobility peptide-Ca21-
CaM complex. At a 1:1 molar ratio of peptide to CaM, all of the
CaM was gel-shifted, and the intensity of the peptide-Ca21-
CaM band was increased as the result of complex formation
(Fig. 3A). At still higher molar ratios, no new band was de-
tected on the gel nor did the peptide-CaM complex band change
in intensity, indicating a 1:1 binding stoichiometry of peptide to
CaM and the absence of multivalent peptide-CaM complexes
(Fig. 3A). Similar results were obtained when gel shift assays
were performed in the presence of 4 M urea. However, in the
presence of Ca21 chelator, EGTA, only the pure CaM bands
were detected on the gel and no peptide-CaM complex band was
visible (Fig. 3B), indicating the complex formation is Ca21-de-
pendent. Peptides from other regions of the Gb subunit had no
effect on the mobility of CaM (data not shown).
Since the synthetic peptide contains a tryptophan residue,
whereas CaM contains none, binding of Gb peptide to CaM was
directly studied by monitoring the changes in tryptophan flu-
orescence (Fig. 4). When the peptide was excited at 295 nm, it
exhibited an intrinsic tryptophan fluorescence emission peak
FIG. 2. Alignment of the putative CaM-binding domain in Gb
subunit with known CaM-binding proteins. The putative CaM-
binding sequences of Gb subunits are compared with the known CaM-
binding domains of rat olfactory cyclic nucleotide-gated channel
(OCNC) (21), skeletal muscle myosin light chain kinase (skMLCK) (40),
plasma membrane Ca21-ATPase (Ca21 pump) (41), calcineurin (42),
Ras-like GTPase Kir/Gem (43), murine-inducible nitric oxide synthase
(Murin iNOS residues 501–532) (44), and CaM kinase II (45). The
conserved hydrophobic residues are boxed and may play an important
role in the interaction with CaM.
FIG. 3. Gel mobility shifting assay of CaM by synthetic peptide.
CaM (10 mg) was incubated with the indicated amount of peptide
derived from Gb subunit in the presence of 1 mM CaCl2 (A) or 2 mM
EGTA (B). Samples were then separated on 12% nondenaturing poly-
acrylamide gels containing either CaCl2 or EGTA. The relative mobility
of CaM and CaM-peptide complex was visualized by Coomassie Blue
staining. The molar ratios of peptide to CaM are shown as indicated.
The results are representative of three separated experiments.
FIG. 1. Binding of G protein bg subunits to Ca21-CaM. A, inter-
action of rat brain Gbg subunits with Ca21-CaM. Purified rat brain bg
subunits were incubated with CaM-agarose in the presence of 1 mM
CaCl2 for 30 min at room temperature. Then, the CaM-agarose com-
plexes were washed extensively with phosphate-buffered saline con-
taining CaCl2. Proteins bound to CaM-agarose were eluted with buffer
containing EGTA. Eluted Gb protein was visualized by Western blot
using specific antibodies against Gb subunits. Con, control. B, binding
of Gb5Lg subunits to Ca
21-CaM. Gb5Lg extracts were obtained from
bovine retina and were then applied to a CaM-Sepharose fast protein
liquid chromatography column (Pharmacia) equilibrated with Ca21-
containing buffer. Proteins bound to the CaM-Sepharose column were
then eluted with an EDTA-containing buffer. 20 ml of the indicated
fractions were separated by 10% SDS-PAGE and immunoblotted using
the Gb5-specific antiserum CT215.
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at 353 nm. Addition of CaM in the presence of Ca21 not only
caused a blue shift of the fluorescence peak but also increased
the maximal fluorescence intensity (Fig. 4A). Since Ca21 alone
has no effect on the emission spectrum, the observed change
must have resulted from the binding of Ca21-CaM to the pep-
tide. The blue shift in fluorescence emission and the increase in
total intensity indicate that the environment of the Gb peptide
became hydrophobic, presumably due to interactions with the
hydrophobic domains of CaM upon formation of complex, fur-
ther confirming the CaM binding property of the peptide. The
changes in fluorescence property upon formation of the pep-
tide-CaM complex were fully reversed by the addition of EGTA
(Fig. 4A), indicating that the binding of CaM to the peptide is
Ca21-dependent. Titration of fixed amounts of peptide with
different concentrations of CaM showed a saturation pattern.
As shown in Fig. 4B, when a 0.1 mM concentration of peptide
was used, the fluorescence intensity increased almost linearly
with increasing CaM concentrations and reached a plateau at
0.1 mM CaM, confirming a 1:1 tight binding between the peptide
and CaM. When the fraction of bound peptide was plotted as a
function of free CaM concentration, the dissociation constant
(Kd) obtained was ;40 nM (Fig. 4C), indicating high affinity
binding to Ca21-CaM. The actual binding affinity could be
higher than 40 nM; however, the limitation of this fluorescence
measurement does not allow us to test low peptide
concentration.
Mutation Analysis of the Putative CaM-binding Domain of
Gb Subunits—To identify the key amino acids essential for
CaM binding, two types of mutations were carried out in the
putative CaM-binding domain by site-directed mutagenesis.
One set contains a number of basic amino acid residues (Arg-
42, Arg-48, Arg-49), and the other group involves hydrophobic
residues (Ile-43, Leu-51, Leu-55). These specific amino acids
were individually replaced by alanine residues. Mutant pro-
teins were then compared with wild type protein for their
ability to bind Ca21-CaM. Both wild type and mutant cDNA
were translated in vitro together with g2 subunit in rabbit
reticulocyte lysates in the presence of 35S-labeled methionine.
Fig. 5A shows the in vitro translated wild type and mutant Gb
proteins separated by SDS-gel and detected by autoradiogra-
phy. The amount of wild type protein and mutant proteins
synthesized are similar under these assay conditions. The in
vitro translated protein mixtures were incubated with CaM-
agarose beads to assess the CaM binding ability. After exten-
sive washing with Ca21-containing buffer (100–200 bead vol-
ume), the bound protein was eluted with EGTA buffer. As
shown in Fig. 5B, like the wild type Gb protein, one of the
mutants (R42A) retained its ability to bind CaM. However, the
binding affinities of other mutants (I43A, L55A, R48A/R49A,
and L51A) for CaM were reduced by varying degrees under the
same assay conditions. For instance, mutations at residues
Arg-48, Arg-49, and Leu-51 dramatically reduced the CaM
binding ability of the protein (Fig. 5B), suggesting that these
residues are critical in the interactions. To further probe the
conformation and activity of mutant Gb subunits, we analyzed
the formation of bg dimers using in vitro translated proteins
and coimmunoprecipitation with specific anti-Gg2 antibodies.
The wild type Gb and its mutant proteins can be precipitated
by g2 antibodies, and there is little difference in their ability to
interact with g subunits (data not shown), indicating that mu-
titrated with different concentrations of CaM in the presence of 0.5 mM
CaCl2. C, determination of the affinity constant for the interaction
between CaM and Gb peptide. The fraction of bound peptide was
calculated and plotted against free CaM concentration. The curve was
fitted by a ligand binding equation with a dissociation constant of
;40 nm.
FIG. 4. Direct interaction of calmodulin with Gb peptide as-
sayed by measuring the changes in tryptophan fluorescence
spectrum. A, Ca21-dependent interactions of the Gb peptide with
CaM, measured by the emission spectrum of the peptide and peptide-
CaM complex. When the peptide (0.1 mM) was excited at 295 nm, the
peptide exhibited a fluorescence emission spectrum with a maximal
emission peak at 354 nm (peptide w/Ca21). In the presence of Ca21,
addition of CaM not only caused a blue shift of the fluorescence peak but
also increased the total fluorescence intensity (peptide 1 Ca21-CaM).
Addition of EGTA completely reversed these fluorescence changes (pep-
tide 1 Ca21-CaM 1 EGTA), indicating that the interactions between
the Gb peptide and CaM is Ca21-dependent. B, the Gb peptide was
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tant b subunits could still fold into the native conformation and
retain affinity for g subunits.
Effects of CaM Binding on ADP-ribosylation of Gao Sub-
units—To explore the possible physiological functions of CaM
binding to Gbg subunits, we first examined the effects of CaM
binding on bg-dependent pertussis toxin-catalyzed ADP-ribo-
sylation of Gao subunit. PTX is a bacterial toxin that catalyzes
the ribosylation of the C-terminal cysteine residues of Gao,
Gai, and Gat subunits. PTX modification blocks the interac-
tions of Ga subunits with receptors and thus blocks the ligand-
mediated signal transduction. The labeling of Gao by PTX
requires the Gaobg heterotrimer rather than the free Gao
subunit (33). Thus, ADP-ribosylation of ao can be used as a
sensitive indicator of formation of aobg heterotrimers. Incuba-
tion of CaM with bovine brain Gbg subunits in the presence of
0.1 mM Ca21 inhibited the ribosylation reaction, as shown in
Fig. 6. The reduction of labeling is concentration-dependent. At
equal molar concentrations of CaM and bg subunits, the PTX-
catalyzed ribosylation of Gao was almost completely blocked by
Ca21-CaM. Since Ca21 alone had no effect on the reaction, the
simplest interpretation of this observation is that Ca21-CaM
formed a complex with Gbg subunits and this complex lost its
ability to interact with Gao subunit; therefore, CaM inhibited
the bg-dependent ADP-ribosylation of Gao.
Binding of CaM to Gbg Has Little Effect on bg-activated
PLC-b2 Activity—To further investigate the nature of CaM
binding on Gbg subunits, we examined its effects on bg-stim-
ulated PLC-b2 activity. As shown in Fig. 7A, CaM has little
effect on PLC-b2 activity stimulated by bg subunits in an in
vitro reconstituted system. To confirm the observations ob-
tained in the reconstitution experiments, cDNAs encoding
PLC-b2, Gbg, and CaM were transfected into COS-7 cells.
Coexpression of PLC-b2 and bg subunits increased inositol
1,4,5-trisphosphate release 3–5 fold (Fig. 7B, column 3). How-
ever, cotransfection of CaM expression plasmids had little ef-
fect on the bg-stimulated PLC-b2 activity (Fig. 7B, column 4).
These results indicated that in the Gb subunit, the domain
responsible for PLC-b2 activation is distinct from the domain
binding to CaM, suggesting that different domains of the b
subunit are involved in interactions with different effector
proteins.
Inhibition of Ca21-CaM-dependent Enzyme, CaM Kinase II,
by Gbg Subunits and Its Peptide—The putative CaM-binding
domain of Gb subunits was further characterized by using the
synthetic peptide derived from Gb to inhibit Ca21-CaM-de-
pendent activation of CaM kinase II. Concentration-dependent
effects of the peptide on CaM kinase II activity were examined.
As shown in Fig. 8A, the peptide was a potent inhibitor of CaM
kinase II activity. At a 1:1 binding ratio of Gb peptide to CaM,
the peptide totally inhibited the Ca21-CaM-dependent activa-
tion of CaM kinase II, suggesting that the binding affinity of
Gb peptide is comparable to the affinity of CaM kinase II
toward Ca21-CaM and should be in the nM range. Other pep-
tides from the N-terminal regions had no effect on the Ca21-
CaM-stimulated enzymatic activity (data not shown). To exam-
ine whether Gbg subunits can also inhibit the Ca21-CaM-
dependent CaM kinase II activity, Ca21-CaM was incubated
with brain Gbg subunits for 30 min at room temperature. Then
the Ca21-CaM-stimulated CaM kinase II activity was assayed.
Fig. 8B shows that brain Gbg subunits inhibited 70–80% of
Ca21-CaM-stimulated CaM kinase II activity, indicating that
bg can competitively bind to Ca21-CaM.
DISCUSSION
Previous studies have demonstrated that G protein subunits
can act as potent inhibitors of the Ca21-CaM-stimulated phos-
phodiesterase activity (23, 24), probably through interactions
of Gbg with CaM. In this report, we show direct binding of Gbg
subunits with CaM. This CaM-binding property of Gb is Ca21-
dependent and conserved in known Gb subunits, including the
most diverse b5 subunit. We also identified and characterized
the CaM-binding domain in bg subunits using three different
methods. In the gel mobility shifting assays and tryptophan
fluorescence assay, a conserved 25-amino acid peptide in the
N-terminal region of Gb subunits was found to interact with
CaM. By modifying specific amino acids in this region, we
identified some key residues (Arg-48, Arg-49, Leu-51, Ile-43,
Leu-55) that play an important role in the binding of bg to
CaM.
The interaction between Gbg subunits and CaM is Ca21-de-
pendent. Ca21 is an important intracellular messenger in
many cellular functions including cell growth and development
(34, 35). Many seven-transmembrane receptors activate the G
protein subunits, which in turn activate PLC-b, resulting in the
production of inositol 1,4,5-trisphosphate and diacyglycerol
from PtdInsP2. Inositol 1,4,5-trisphosphate acts as an intracel-
lular second messenger by binding to the inositol 1,4,5-
trisphosphate receptors in the endoplasmic reticular mem-
FIG. 5. Mutation analysis of putative CaM-binding domain of
Gb subunit. A, similar amounts of wild type (wt) and mutant Gb1
proteins were obtained by in vitro translation in rabbit reticulocyte
lysates (Promega). B, CaM binding of in vitro translated Gb protein and
its mutants. Compared with wild type Gb protein, the mutant protein
(R42A) retained its binding ability to Ca21-CaM; however, other mu-
tant proteins (R48,49A, L51A, I43A, and L55A) showed weak binding
ability to Ca21-CaM, especially mutations at residues Arg-48, Arg-49,
and Leu-51.
FIG. 6. CaM inhibited Gbg-dependent PTX-catalyzed ADP-ri-
bosylation of Gao. 0.1 mg of recombinant Gao was mixed with 0.1 mg
of purified bovine brain bg complex in the presence of indicated molar
ratios of CaM. The reaction mixture was incubated for 10 min at room
temperature.
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brane, triggering the release of Ca21 from the endoplasmic
reticulum and therefore increasing the intracellular Ca21 con-
centration. Ca21 is also believed to organize and stabilize CaM
domain structure in a conformational state that can bind target
proteins (32, 36). The calmodulin concentration in some cells,
e.g. neuronal cells, is in the order of micromolar. Calcium
release can thus convert 10–50% of these molecules to the
Ca21-bound form. The affinity of Gbg for Ca21-CaM is suffi-
ciently high so that under these conditions much of the free bg
in the cells should be in the CaM-bound form. Therefore, an
increase in intracellular Ca21 concentration could selectively
regulate the interactions of Gbg with a number of other pro-
teins through binding with CaM.
The interaction of Gbg with Ca21-CaM could play an impor-
tant role in the cross-talk mechanism between different G
protein pathways (37). Ca21-CaM has been shown to regulate
the formation and hydrolysis of cAMP. In the Gas-coupled
pathway, both adenylyl cyclases and phosphodiesterases are
Ca21-CaM-dependent, which could serve as the convergence
point for Ca21-dependent and Gas-dependent stimuli.
FIG. 7. Calmodulin has little effect on Gbg-stimulated PLC-b2
activity. A, in vitro reconstitution assay of PLC-b2 activity. The Gbg-
activated PLC-b2 activity was assayed in a reaction mixture containing
PLC-b2, brain or retinal Gbg, 50 mM CaCl2, 10 mM LiCl, phospholipid
vesicles, and different concentrations of CaM. The released inositol
1,4,5-trisphosphate (IP3) was extracted, separated, and subjected to
scintillation counting. B, in vivo transfection assays of PLC-b2 activity.
Accumulation of inositol phosphates was measured in COS-7 cells
transfected with expression vectors carrying cDNAs corresponding to
b-galactosidase (lacZ), PLC-b2, Gb1, Gg2, and CaM. The cDNAs trans-
fected are indicated beneath each column.
FIG. 8. Inhibition of Ca21-CaM stimulated CaM kinase II activ-
ity by Gbg and its CaM-binding peptide. A, the putative CaM-
binding peptides derived from Gb inhibited the Ca21-CaM-dependent
CaM kinase II activity. Different molar ratios of Gb peptide were
incubated with CaM, then added to the kinase assay mixture. The final
concentration of CaM was kept the same in all the reactions. B, inhib-
itory effects of brain Gbg on CaM kinase II activity. At equal molar
ratios, Gbg can compete for CaM, inhibiting the Ca21-CaM-dependent
CaM kinase II activity.
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The primary structure of the identified CaM-binding domain
of Gbg shows features similar to some other CaM-binding
proteins and inhibitors (21, 28, 38–45). For instance, the iden-
tified b CaM-binding domain contains a high percentage of
hydrophobic residues and an excess of positively charged resi-
dues, a property found in all CaM-binding peptides. It is be-
lieved that the basic residues contribute to CaM binding via
electrostatic interactions with acidic residues in CaM, whereas
the hydrophobic amino acids seem to play a more important
role in CaM binding through interactions with the hydrophobic
patches of the globular domains of CaM (38, 39). From x-ray
structural analysis, 80% of all contacts are van der Waals
interactions, and the interaction appears to involve two key
hydrophobic amino acids separated by eight residues, although
flexibility does exist in the interaction because of the flexible
central helix of CaM (36). CaM contains two globular domains,
and these two domains are connected by a long alpha helical
segment (32, 36). When different CaM binding targets are
recognized, this long central segment allows different relative
positioning of the two lobes of CaM. Therefore, although the
secondary structure of the Gb CaM-binding domain is not a
typical amphipathic a helix (46), CaM could still position itself
to bind to the Gb protein, possibly by stabilizing a change in the
conformation of the N-terminal domain of Gb protein. On the
other hand, a number of CaM-binding proteins have been iden-
tified and shown to contain sites that are not typical am-
phipathic helices but consist of basic amino acids interspersed
with nonpolar amino acids (52–54).
The binding of CaM to Gbg interfered with the formation of
Gabg trimers as assayed by the inhibition of PTX-catalyzed
ADP-ribosylation of Gao. Based on the secondary structure of
the b subunit, the N-terminal region of the b subunit is in close
proximity to the N-terminal portion of Ga subunit (47–49). It
has been reported that effector activation by the bg subunits is
blocked upon the addition of the Ga subunit presumably by
heterotrimerization (1, 13). Thus, by interacting with the N-
terminal domain of b subunit, the Ca21-CaM complex could
affect the heterotrimer formation of Gabg.
Interaction of CaM with bg has little effect on the G protein
bg subunit-activated PLC-b2 activity. These results support
the notion that interaction of different bg-responsive effectors
is mediated by distinct domains of Gbg (50, 51). By using a
series of chimeras between Dictyostelium and mammalian b
subunits, a small C-terminal segment of Gb was identified as
responsible for the activation of PLC-b2 (50). The CaM-binding
domain of Gb identified in this report is located in the N-
terminal region. This region of Gb was suggested to play a role
in the interaction of adenylyl cyclase type 2, the muscarinic
receptor-gated atrial inwardly rectifying potassium channel
(GIRK1), and in the activation of mitogen-activated protein
kinase pathways (50, 51). It will be of great interest to deter-
mine whether binding of CaM to Gbg can affect the activation
of the potassium channels (GIRK) and mitogen-activated pro-
tein kinase pathways.
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